Transparency is the Victim
By The Hindu,
The Hindu
| 01. 27. 2013
Expansion and proliferation of assisted reproductive technologies (ART) has been facilitated by economic globalisation wherein reproductive tissues like sperm, ova, and uteri are traded like any other commodity to make profit, says a new study, adding that India has emerged as the surrogacy outsourcing capital of the world.
Titled ‘Reproductive Tourism in India: Actors, Agencies and Contemporary Transnational Networks’, the study was conducted by the Centre of Social Medicine and Community Health, JNU, Sama-Resource Group for Women and Health and King’s College London.
The study focuses on the scenario in New Delhi where a large number of private hospitals and government institutions offer ART. It was found that public sector institutions offer only altruistic surrogacy services which are medically indicated. Leading obstetricians and gynaecologists from a top government-run hospital admitted that they have performed in-vitro fertilisation (IVF) in some cases where they were not sure if it was altruistic surrogacy.
One doctor said that she once had a patient, a doctor by profession who bore a surrogate baby for her sister-in-law who was also a doctor, married to a doctor...
Related Articles
Reproductive rights have been a flashpoint in national politics for decades, with the stakes surging after the Supreme Court shredded the right to an abortion. In the current presidential campaign, the battle over abortion has swelled and morphed to encompass in vitro fertilization (IVF), which has now moved rapidly from widely accepted to partisan hot button.
This dramatic shift was highlighted by the February decision of the Alabama Supreme Court that granted personhood rights to frozen IVF embryos, signaling that...
By Sara Moretto, The Varsity | 09.22.2024
It was 2020. I was wrapping up grade nine science with a solid 60 per cent, hoping that if anyone saw my failed tests in the recycling bin, it would contribute to an air of mystery about me. This reason...
By Don Sapatkin, Managed Healthcare Executive | 09.20.2024
Gene therapy comes with the expectation that it will “cure” an expanding number of genetic disorders. If you’ve never wondered – and even if you have -- what that word actually means, four Dutch researchers have a surprise in store...
By Heidi Ledford, Nature | 09.17.2024
For most of her life, Genesis Jones’s daily routine revolved around her illness, the painful blood disorder known as sickle-cell disease. Each time she left the house, she ran through a mental checklist: did she have her pain medications...